Basiliximab has been evaluated and proven effective in phase III studies on the prophylaxis of acute rejection after renal transplantation. The frequency of immune responses to basiliximab was very ...
Learn everything you need to know about Basiliximab-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...
Review the side-effects of Basiliximab as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
My patient had a severe anaphylactoid reaction (capillary leak syndrome) to basiliximab during renal transplantation. What is the treatment? I would like to know of similar experiences. In a personal ...
November 8, 2006 — Induction therapy with rabbit antithymocyte globulin, compared with basiliximab, was linked with a lower incidence of acute rejection but a similar 1-year incidence of delayed graft ...
After allogeneic stem cell transplant, severe grade III–IV gastrointestinal (GI) acute GvHD is associated with significant morbidity and mortality, and generally results in poor outcomes. Salvage ...
There are few comparisons of antibody induction therapy allowing early glucocorticoid withdrawal in renal-transplant recipients. The purpose of the present study was to compare induction therapy ...
The Pharmacy and Poisons Board (PPB) has issued a public alert warning of falsified SIMULECT (basiliximab), a medication primarily used to prevent organ rejection following kidney transplants, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results